Tirzepatide: Tirzepatide, a dual GIP/GLP-1 agonist, represents a newer generation of metabolic peptides with potent weight loss effects through combined appetite suppression and metabolic enhancement
Linkova NS, Khavinson VKh, Chalisova NI, Katanugina AS, Koncevaya EA
Its primary distinction is its dual-pathway mechanism (VEGFR2 + NO) combined with its gastric stability making it the only compound in this group with demonstrated activity when administered orally in animal models, not just by injection
Patients seeking HCG typically access it through private clinics operating outside NHS governance frameworks
SECTION 5 Fire-Fighting Measures Extinguishing Media: CO, dry chemical, foam, or water spray